Elranatamab,Dexamethasone
Pfizer
['multiple myeloma', 'pfizer']
at #asco23, don t miss our oral presentation on a pooled analysis from the magnetismm program of a bcma-cd3 bispecific antibody in patients with relapsed/refractory multiple myeloma who received prior bcma-directed therapies.
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ